AGL
agilon health, inc.
+1.86 (+2.08%)91.52USD81.4K成交股數1.5B市值–本益比(近四季)0.3股價營收比+7.2%營收年增(近四季)2026-11-03下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 1.5B-2% | 1.4B-7% | 1.4B-1% | 1.4B-6% | 1.5B-4% | 1.5B+34% | 1.5B+36% | 1.5B+41% | 1.6B | 1.1B | 1.1B | 1.1B |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | – | – | – | – | – | – | – | – | – | – | – | – |
| 銷售管理費用 | 88.5M | 54.2M | 56.2M | 56.3M | 66.0M | 59.8M | 63.1M | 69.6M | 76.4M | 72.1M | 79.3M | 69.8M |
| 營業利益 | 11.8M-153% | 4.0M-104% | −131M-2% | −116M+168% | −22.1M+208% | −108M+175% | −134M+361% | −43.3M-10494% | −7.2M | −39.3M | −29.0M | 417K |
| 營業利益率 | 0.8% | 0.3% | -9.1% | -8.3% | -1.4% | -7.1% | -9.2% | -2.9% | -0.4% | -3.5% | -2.7% | 0.0% |
| 稅後淨利 | 18.0M+48% | 48.9M-146% | −110M-6% | −104M+240% | 12.1M-300% | −106M+237% | −118M+602% | −30.7M-291% | −6.1M | −31.4M | −16.7M | 16.0M |
| 淨利率 | 1.2% | 3.4% | -7.7% | -7.5% | 0.8% | -6.9% | -8.1% | -2.1% | -0.4% | -2.8% | -1.6% | 1.5% |
| 稀釋 EPS | 1.04+42% | 2.94 | – | -6.31 | 0.73 | – | – | – | – | – | – | – |
| 稀釋股數 | 17.2M | 16.7M | 414M | 16.6M | 16.5M | 411M | 412M | 411M | 409M | 406M | 410M | 427M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 107M | 140M | 172M | 171M | 137M | 188M | 148M | 109M | 112M | 168M | 191M | 394M |
| 應收帳款 | 1.1B | 900M | 947M | 1.0B | 1.2B | 1.0B | 1.4B | 1.4B | 1.6B | 1.3B | 1.4B | 1.0B |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 1.6B | 1.5B | 1.6B | 1.7B | 1.9B | 1.7B | 2.1B | 2.2B | 2.3B | 2.3B | 2.4B | 2.2B |
| 有息負債 | 15.4M | 15.3M | 0.00 | 0.00 | 0.00 | 34.9M | 34.9M | 27.4M | 29.8M | 34.8M | 36.0M | 37.2M |
| 總負債 | 1.4B | 1.3B | 1.3B | 1.3B | 1.4B | 1.3B | 1.5B | 1.5B | 1.6B | 1.4B | 1.5B | 1.1B |
| 股東權益 | 228M | 181M | 306M | 409M | 500M | 471M | 575M | 677M | 689M | 872M | 880M | 1.1B |
| 負債比 | 85.7% | 87.9% | 80.8% | 76.1% | 74.1% | 72.8% | 72.5% | 68.8% | 70.3% | 61.7% | 62.6% | 50.2% |
| 淨現金(現金 − 有息負債) | 91.8M | 125M | 172M | 171M | 137M | 153M | 113M | 82.1M | 81.9M | 134M | 155M | 357M |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | 23.7M | – | – | −32.0M-33% | – | – | – | −47.8M | – | – | −60.8M |
| 資本支出 | – | 3.1M | – | – | 3.8M | – | – | – | 3.1M | – | – | 3.7M |
| 自由現金流 | – | 20.6M | – | – | −35.8M-30% | – | – | – | −50.9M | – | – | −64.5M |
| 折舊攤銷 | 6.9M | 6.8M | 7.4M | 7.3M | 6.9M | 6.5M | 6.2M | 5.9M | 5.8M | 4.1M | 4.3M | 4.2M |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | 1.5% | – | – | -2.3% | – | – | – | -3.2% | – | – | -6.1% |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
產品／服務2025 年度 · 5.9B
| Medical Services | 5.9B | 99.8% | -2.1% |
|---|---|---|---|
| Other Operating | 11.2M | 0.2% | -12.3% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 5.9B | -2.1% | −391M | -6.6% | – | −119M |
| FY2024 | 6.1B | +40.4% | −260M | -4.3% | – | −71.0M |
| FY2023 | 4.3B | +80.7% | −263M | -6.1% | – | −172M |
| FY2022 | 2.4B | +57.0% | −107M | -4.5% | – | −146M |
| FY2021 | 1.5B | +24.9% | −406M | -26.7% | – | −155M |
| FY2020 | 1.2B | +53.4% | −60.1M | -4.9% | – | −55.0M |
| FY2019 | 794M | – | −283M | -35.6% | – | −107M |